{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Agile Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"AGRX"},"Address":{"label":"Address","value":"500 COLLEGE ROAD EAST SUITE 310, PRINCETON, New Jersey, 8540, United States"},"Phone":{"label":"Phone","value":"+1 609 683-1880"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin."},"CompanyUrl":{"label":"Company Url","value":"https://www.agiletherapeutics.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Alfred F. Altomari","title":"Chairman &amp; Chief Executive Officer"},{"name":"Paul Korner","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}